Penttala M, Sorsa T, Thomas J, Grigoriadis A, Sakellari D, Gupta S
Diagnostics (Basel). 2025; 15(3).
PMID: 39941225
PMC: 11816464.
DOI: 10.3390/diagnostics15030296.
Hopealaakso T, Thomas J, Patila T, Penttala M, Sakellari D, Grigoriadis A
Diagnostics (Basel). 2025; 14(24.
PMID: 39767238
PMC: 11675138.
DOI: 10.3390/diagnostics14242878.
Domokos Z, Simon F, Uhrin E, Szabo B, Vancsa S, Varga G
Heliyon. 2024; 10(22):e40402.
PMID: 39641024
PMC: 11617734.
DOI: 10.1016/j.heliyon.2024.e40402.
Zhang Q, Wang Z, Shen S, Wang J, Cao J, Deng Y
Front Cell Infect Microbiol. 2024; 14:1494651.
PMID: 39554809
PMC: 11564189.
DOI: 10.3389/fcimb.2024.1494651.
Werner N, Frasheri I, Heck K, Ern C, Heym R, Bumm C
Clin Oral Investig. 2024; 28(10):523.
PMID: 39269543
PMC: 11399289.
DOI: 10.1007/s00784-024-05904-y.
Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
Raisanen I, Aji N, Sakellari D, Grigoriadis A, Rantala I, Patila T
Biomedicines. 2023; 11(11).
PMID: 38001886
PMC: 10669684.
DOI: 10.3390/biomedicines11112885.
aMMP-8 POCT for Periodontal Disease: An Indicator of Poor Oral Health.
Gupta S, Raisanen I, Seppanen H, Hagstrom J, Grigoriadis A, Hermunen K
Cancer Control. 2023; 30:10732748231214874.
PMID: 37964755
PMC: 10647922.
DOI: 10.1177/10732748231214874.
aMMP-8 Point-of-Care Test (POCT) Identifies Reliably Periodontitis in Patients with Type 2 Diabetes as well as Monitors Treatment Response.
Heikkinen A, Sokka T, Torppa-Saarinen E, Pimia E, Jokinen M, Maijala M
Diagnostics (Basel). 2023; 13(13).
PMID: 37443617
PMC: 10340192.
DOI: 10.3390/diagnostics13132224.
Applicability of an active matrix metalloproteinase-8 point-of-care test in an oral and maxillofacial surgery clinic: a pilot study.
Kallio E, Puolakkainen T, Tervahartiala T, Snall J, Marttila E, Sorsa T
Odontology. 2023; 112(1):250-255.
PMID: 37249720
PMC: 10776480.
DOI: 10.1007/s10266-023-00821-0.
Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
Gupta S, Mohindra R, Singla M, Khera S, Kumar A, Rathnayake N
Clin Exp Dent Res. 2022; 8(4):988-1001.
PMID: 35818743
PMC: 9350191.
DOI: 10.1002/cre2.589.
aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases.
Sorsa T, Nwhator S, Sakellari D, Grigoriadis A, Umeizudike K, Brandt E
Front Oral Health. 2022; 3:897115.
PMID: 35757444
PMC: 9226345.
DOI: 10.3389/froh.2022.897115.
Implementing of aMMP-8 point-of-care test with a modified new disease classification in Finnish adolescent cohorts.
Heikkinen A, Raivisto T, Raisanen I, Tervahartiala T, Bostanci N, Sorsa T
Clin Exp Dent Res. 2022; 8(5):1142-1148.
PMID: 35676762
PMC: 9562567.
DOI: 10.1002/cre2.603.
The Role of Epigenetic and Biological Biomarkers in the Diagnosis of Periodontal Disease: A Systematic Review Approach.
Faulkner E, Mensah A, Rodgers A, McMullan L, Courtenay A
Diagnostics (Basel). 2022; 12(4).
PMID: 35453967
PMC: 9029524.
DOI: 10.3390/diagnostics12040919.
Active matrix metalloproteinase-8: A potential biomarker of oral systemic link.
Umeizudike K, Raisanen I, Gupta S, Nwhator S, Grigoriadis A, Sakellari D
Clin Exp Dent Res. 2021; 8(1):359-365.
PMID: 34800007
PMC: 8874056.
DOI: 10.1002/cre2.516.
Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
Sorsa T, Sahni V, Buduneli N, Gupta S, Raisanen I, Golub L
Expert Rev Proteomics. 2021; 18(8):707-717.
PMID: 34468272
PMC: 8442753.
DOI: 10.1080/14789450.2021.1976151.
